Security key
17322U207
- Security type / class
- Equity / COM
- Total 13F shares
- 968,883
- Total 13F value
- $1,086,000
- Share change
- -1,166,452
- SEC-reported price per share
- $1.12
- Number of holders
- 13
- Value change
- -$543,067
- Number of buys
- 10
- Number of sells
- 4
Report period
Q2 2020
Institutions
13
Top holders
10
CTXR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Citius Pharmaceuticals, Inc. SEC filings
Citius Pharmaceuticals, Inc. company facts
Citius Pharmaceuticals, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 17322U207
Recent filing periods:
Ownership snapshot
Top reported holders of CTXR - CITIUS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
0/10
Latest evidence
31 Mar 2020
13F
Highest disclosed value: $813,000
10 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
SABBY MANAGEMENT, LLC has the largest disclosed position value at $813K.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Disclosed position value
Top 5
SABBY MANAGEMENT, LLC
$813K
VANGUARD GROUP INC
$279K
Argent Wealth Management LLC
$113K
RENAISSANCE TECHNOLOGIES LLC
$55K
WELLS FARGO & COMPANY/MN
$11K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$813,000
1,354,275 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$279,000
464,406 shares
|
— | 31 Mar 2020 |
| Argent Wealth Management LLC |
13F
Company
|
—
denominator unverified
|
$113,000
164,444 shares
|
— | 31 Mar 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$55,000
92,300 shares
|
— | 31 Mar 2020 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$11,000
18,500 shares
|
— | 31 Mar 2020 |
| NORTHERN TRUST CORP |
13F
Company
|
—
denominator unverified
|
$10,000
16,947 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
968,883
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2020 holders
13
Holder diff
12
| Investor | Q3 2025 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend